Chronic Myeloid Leukemia (CML) is a rare form of blood cancer that starts in the bone marrow and primarily affects the white blood cells. This slow-progressing disease is often linked to a genetic abnormality known as the Philadelphia Chromosome, where parts of chromosome 9 and 22 swap places, leading to the formation of the BCR-ABL gene. This gene produces an abnormal enzyme that accelerates the growth of leukemic cells, causing them to multiply uncontrollably.
CML typically progresses over time, making early detection crucial for effective management. While it can affect individuals of all ages, it is most commonly diagnosed in middle-aged adults, particularly those over 40. If left untreated, CML can advance from a chronic stage to a more aggressive phase, making it critical to understand the symptoms, stages, and treatment options available for this condition.
Table of Contents
Stages Of Chronic Myeloid Leukemia
CML progresses through three stages, each with distinct characteristics and symptoms. Early diagnosis and prompt treatment at each stage can significantly improve outcomes. CML progresses with three stages, each with distinct characteristics and symptoms.
Also Read- Childhood Leukemia- Survival Rate, Types, Treatment Options & More
1. Chronic Phase:
In the initial stage, CML is typically diagnosed when symptoms are mild or even absent. Common symptoms may include night sweats, discomfort in the ribcage, fatigue, and unexplained weight loss. At this point, the disease is usually manageable with modern treatments like Tyrosine Kinase Inhibitors (TKIs), which help control the growth of cancerous cells. This stage is the most treatable, and patients often respond well to therapy.
2. Accelerated Phase:
As the disease progresses, the number of abnormal cells increases, leading to more pronounced symptoms such as weakness, fatigue, and a decrease in platelet counts, which can result in blood clotting issues and abnormal bleeding. During this phase, doctors often adjust the dosage of TKIs or recommend chemotherapy to control the disease.
3. Blast Crisis Phase:
The blast crisis phase is the most advanced and aggressive stage of CML. The number of blasts (immature cells) in the blood or bone marrow exceeds 20%, and symptoms become more severe, including bone pain, uncontrolled bleeding, and complications involving multiple organs. At this stage, the disease resembles acute leukemia, and treatment becomes more challenging. Patients may require a combination of intensified therapy, such as chemotherapy, stem cell transplantation, or higher doses of TKIs.
The strategies and techniques used for the treatment can vary depending on the phase of CML. Diagnosis helps with the recognition of the ongoing phase which helps in implementing the best treatment required and how well the disease responds to the therapy.
Symptoms Of Chronic Myeloid Leukemia
CML symptoms vary depending on the stage of the disease. Early symptoms may be mild and mistaken for common illnesses, but as the disease progresses, the severity of symptoms increases.
Some of the common symptoms experienced by patients with CML are:
- Fever: A constant low-grade fever.
- Discomfort in the abdomen: Enlargement of the spleen (splenomegaly) causes a feeling of fullness or discomfort in the upper left abdomen. Unconditional Weight loss: A drastic weight reduction that too unintentional.
- Weakness: An effect related to anaemia, the body is unable to carry a sufficient amount of oxygen efficiently.
- Fatigue: The demand for excessive white blood cells increases.
- Sweating at Night: Sweating in a great amount for no obvious reasons.
Moderate symptoms:
- Frequent Infection Problems: The abnormal functioning of the white blood cells in the body affects the immune system.
- Persistently experiencing fatigue: The fatigue worsens, ‘‘interfering with the daily activities of the patient causing great difficulties’’.
- Bone and joint strain: Leukemic cells accumulate in the bone marrow, causing discomfort.
- Drastic weight loss: Continued weight loss without dietary changes or exercise.
Severe Symptoms:
Symptoms in the severe stage can be extremely painful and require immediate attention from the medical and health facility, failure to get treatment at this phase of CML can often lead to life-threatening consequences.
- Shortness of Breath: Anemia can severely hinder the body’s ability to transport oxygen.
- Uncontrolled Bleeding: Low platelet counts lead to serious bleeding, particularly in the gastrointestinal tract or brain.
- Frequent Infections: The immune system is severely compromised, leaving the body vulnerable to infections.
Diagnosis Of Chronic Myeloid Leukemia
Diagnosing CML involves several steps. Many patients show mild or no symptoms in the early stages, but common indicators include fatigue, unintended weight loss, and night sweats. Blood tests, particularly a Complete Blood Count (CBC), are essential for detecting abnormalities in white blood cells, particularly neutrophils and immature cells. The presence of immature granulocytes can be a key marker for CML.
To confirm the diagnosis, doctors perform additional tests to detect the Philadelphia chromosome or the BCR-ABL gene. Common diagnostic tools include:
– Fluorescence in situ hybridization (FISH): Detects specific genetic markers, such as the Philadelphia chromosome.
– Cytogenetic Analysis: Examines the chromosomes in cells to identify translocations.
– Polymerase Chain Reaction (PCR): Detects the BCR-ABL gene in blood or bone marrow.
Bone marrow biopsy helps determine the stage of CML and guides treatment decisions. Early detection and monitoring of the BCR-ABL gene enable better management of the disease, particularly with targeted therapies like TKIs.
The Causes Of Chronic Myeloid Leukemia
Several factors can contribute to the development of CML, though the exact cause remains unknown in most cases.
1. Radiation Exposure: High levels of ionizing radiation, such as those experienced during nuclear accidents or radiation therapy for other cancers, increase the risk of CML. Survivors of atomic bomb explosions, like those in Hiroshima and Nagasaki, showed higher incidences of the disease.
2. Age: CML is more common in middle-aged and older adults, with most cases diagnosed between ages 60 and 65.
3. Gender: Men are more frequently diagnosed with CML than women, though the reasons for this disparity are not fully understood.
4. Chemical Exposure: While no strong evidence directly links CML to chemicals, exposure to benzene, a chemical found in gasoline and used in industry, may increase the risk.
5. Genetic Mutation (Philadelphia Chromosome): All cases of CML are associated with the Philadelphia chromosome, a genetic mutation resulting from the swapping of genetic material between chromosomes 9 and 22. This translocation forms the BCR-ABL gene, which drives the growth of leukemic cells.
Most cases of CML occur without any identifiable cause, and the disease is not inherited. Random mutations in the body’s DNA may accumulate with age and trigger the development of CML.
How Can One Prevent Chronic Myeloid Leukemia?
While there is no guaranteed way to prevent CML, reducing exposure to known risk factors may help lower the chances of developing the disease.
1. Avoid Radiation Exposure: Limiting exposure to unnecessary radiation, including medical imaging or radiation therapy, may reduce the risk of CML. Individuals working in industries where radiation exposure is a concern should follow safety protocols to protect themselves.
2. Healthy Lifestyle Choices: Although lifestyle factors like smoking and alcohol consumption are not directly linked to CML, maintaining a healthy lifestyle can reduce the risk of cancers in general. Regular check-ups and early detection of blood abnormalities can help catch the disease in its early stages, improving treatment outcomes.
3. Monitoring High-Risk Individuals: Those with a family history of blood cancer or who have been exposed to radiation should undergo regular health screenings to detect any early signs of CML.
Differences Between Acute Myeloid Leukemia (AML) and Chronic Myeloid Leukemia (CML)
Though both AML and CML affect the myeloid cells in the blood, they differ in several key ways:
Onset and Progression:
– AML: Develops rapidly, with symptoms appearing within weeks or months. It requires aggressive treatment due to its fast progression.
– CML: Develops slowly, often taking years for symptoms to become severe. The disease typically starts in the chronic phase before progressing to the accelerated or blast phases.
Treatment:
– AML: Requires intensive chemotherapy to induce remission, often followed by a bone marrow transplant.
– CML: Managed with targeted therapies like TKIs, which block the abnormal BCR-ABL protein. Many patients can live with CML for years using oral medications.
The Role of Crowdfunding in CML Treatment
Crowdfunding has emerged as a vital resource for patients facing high medical costs, particularly those undergoing long-term treatment for chronic illnesses like CML. In Crowdfunding small amount of money is raised from a large number of people mostly via online platforms. It helps people to reach out a large audience for financial support. Crowdfunding platforms allow individuals to share their stories and raise funds for treatments that may not be covered by insurance, such as targeted therapies, chemotherapy, or stem cell transplants.
For CML patients, crowdfunding can provide financial support for both treatment and ongoing care. It also helps raise awareness about the disease, as personal stories shared on platforms like ImpactGuru can inspire others to donate and support research efforts.
Conclusion
Chronic Myeloid Leukemia (CML) is a complex blood cancer that progresses slowly but can become life-threatening if not treated. Early diagnosis, particularly during the chronic phase, improves treatment outcomes, while advanced stages require more aggressive approaches like chemotherapy or stem cell transplants. Understanding the causes, symptoms, and treatment options available for CML empowers patients and caregivers to take proactive steps in managing the disease.
Crowdfunding plays a crucial role in helping CML patients cover the costs of treatment, offering a lifeline for those facing financial barriers. By raising awareness and funds, individuals and communities can work together to support those affected by CML and continue research efforts for better treatments and potential cures.
